Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells. [electronic resource]

By:

Hou, Zhi-Jie

Contributor(s):

Luo, Xi
Zhang, Wei
Peng, Fei
Cui, Bai
Wu, Si-Jin
Zheng, Fei-Meng
Xu, Jie
Xu, Ling-Zhi
Long, Zi-Jie
Wang, Xue-Ting
Li, Guo-Hui
Wan, Xian-Yao
Yang, Yong-Liang
Liu, Quentin

Producer: 20160229Description: 6326-40 p. digitalISSN:

1949-2553

Subject(s):

Animals
Antinematodal Agents -- pharmacology
Antineoplastic Agents -- pharmacology
Breast Neoplasms -- drug therapy
Cell Line, Tumor
Cell Proliferation -- drug effects
Female
Humans
MCF-7 Cells
Mebendazole -- administration & dosage
Mice
Mice, Nude
Neoplastic Stem Cells -- drug effects
Random Allocation
Xenograft Model Antitumor Assays

Online resources:

Available from publisher's website

In: Oncotarget vol. 6

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells.

APA

Hou Z., Luo X., Zhang W., Peng F., Cui B., Wu S., Zheng F., Xu J., Xu L., Long Z., Wang X., Li G., Wan X., Yang Y. & Liu Q. (20160229). Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells. : Oncotarget.

Chicago

Hou Zhi-Jie, Luo Xi, Zhang Wei, Peng Fei, Cui Bai, Wu Si-Jin, Zheng Fei-Meng, Xu Jie, Xu Ling-Zhi, Long Zi-Jie, Wang Xue-Ting, Li Guo-Hui, Wan Xian-Yao, Yang Yong-Liang and Liu Quentin. 20160229. Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells. : Oncotarget.

Harvard

Hou Z., Luo X., Zhang W., Peng F., Cui B., Wu S., Zheng F., Xu J., Xu L., Long Z., Wang X., Li G., Wan X., Yang Y. and Liu Q. (20160229). Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells. : Oncotarget.

MLA

Hou Zhi-Jie, Luo Xi, Zhang Wei, Peng Fei, Cui Bai, Wu Si-Jin, Zheng Fei-Meng, Xu Jie, Xu Ling-Zhi, Long Zi-Jie, Wang Xue-Ting, Li Guo-Hui, Wan Xian-Yao, Yang Yong-Liang and Liu Quentin. Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells. : Oncotarget. 20160229.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC